GEHC

SEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 2

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,122

F3 · shares: Withholding of shares of GE HealthCare common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units.

SEC source: 0001628280-23-006427 · wf-form4_167789110493534.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,431

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 33% will vest on September 1, 2024, 33% will vest on September 1, 2025, and 34% will vest on September 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-23-042943 · wk-form4_1703890810.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 652,924

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs will settle on March 1, 2024.

SEC source: 0001628280-23-042950 · wk-form4_1703890952.xml · nonDerivative · entry 1

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,024

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis (the "Spin-Off"). The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

F3 · balance_after: This direct ownership total reflects 6 fewer shares of common stock than were reported as directly held on the Form 4 filed by the reporting person on January 5, 2023 as a result of conversion mechanics involved in the Spin-Off.

SEC source: 0001628280-23-042949 · wk-form4_1703890929.xml · nonDerivative · entry 1

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,619

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

SEC source: 0001628280-23-042948 · wk-form4_1703890907.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,042

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

F3 · balance_after: This direct ownership total reflects 1 fewer shares of common stock than were reported as directly held on the Form 4 filed by the reporting person on January 5, 2023 as a result of conversion mechanics involved in the Spin-Off.

SEC source: 0001628280-23-042947 · wk-form4_1703890882.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,064

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

SEC source: 0001628280-23-042946 · wk-form4_1703890860.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

SEC source: 0001628280-23-042945 · wk-form4_1703890837.xml · nonDerivative · entry 1

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,887

F1 · date: Inadvertently filed late due to an administrative error.

F2 · shares: Performance stock units ("PSUs") granted on March 1, 2021 by General Electric Company ("GE") prior to the January 3, 2023 distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") to holders of GE common stock on a pro rata basis. The applicable performance criteria were satisfied and certified by GE's Management Development and Compensation Committee on February 9, 2023. Each PSU represents the right to receive, at settlement, one share of GE HealthCare common stock. The PSUs vest on March 1, 2024, subject to the reporting person's continued employment.

SEC source: 0001628280-23-002258 · wf-form4_167546520581404.xml · nonDerivative · entry 2

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,145

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · shares: Award of restricted stock units with respect to GE HealthCare common stock, of which 50% will vest on February 2, 2024 and 50% will vest on February 2, 2025.

SEC source: 0001628280-23-002262 · wf-form4_167546526401957.xml · derivative · entry 2

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,515

Underlying: Common Stock, par value $0.01 per share · 23,515 shares

Expires 2033-02-01

F3 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002262 · wf-form4_167546526401957.xml · nonDerivative · entry 1

Stacherski Kenneth R. · CIK 0001889865 · Ch. Supply Chain & Serv. Ofc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,008

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-23-002264 · wf-form4_167546529107178.xml · derivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,870

Underlying: Common Stock, par value $0.01 per share · 54,870 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002264 · wf-form4_167546529107178.xml · nonDerivative · entry 1

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,708

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 6,249 newly awarded restricted stock units, 58,274 previously reported restricted stock units, and 185 shares of common stock.

SEC source: 0001628280-23-002266 · wf-form4_167546531200137.xml · derivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,127

Underlying: Common Stock, par value $0.01 per share · 188,127 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002266 · wf-form4_167546531200137.xml · nonDerivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,820

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 21,425 newly awarded restricted stock units and 20,395 previously reported restricted stock units.

SEC source: 0001628280-23-002269 · wf-form4_167546537520559.xml · derivative · entry 2

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,193

Underlying: Common Stock, par value $0.01 per share · 39,193 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002269 · wf-form4_167546537520559.xml · nonDerivative · entry 1

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,631

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 4,463 newly awarded restricted stock units and 49,168 previously reported restricted stock units.

SEC source: 0001628280-23-002270 · wf-form4_167546539828224.xml · derivative · entry 2

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,031

Underlying: Common Stock, par value $0.01 per share · 47,031 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002270 · wf-form4_167546539828224.xml · nonDerivative · entry 1

Zodl Helmut · CIK 0001951654 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,275

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 5,356 newly awarded restricted stock units and 42,919 previously reported restricted stock units.

SEC source: 0001628280-23-002268 · wf-form4_167546535084139.xml · derivative · entry 2

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,244

Underlying: Common Stock, par value $0.01 per share · 17,244 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002268 · wf-form4_167546535084139.xml · nonDerivative · entry 1

O'Neill Kevin Michael · CIK 0001951605 · CEO, PDx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,779

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 1,964 newly awarded restricted stock units and 22,815 previously reported restricted stock units.

SEC source: 0001628280-23-002267 · wf-form4_167546533085877.xml · derivative · entry 2

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,487

Underlying: Common Stock, par value $0.01 per share · 5,487 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002267 · wf-form4_167546533085877.xml · nonDerivative · entry 1

Newcomb George A. · CIK 0001952158 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,472

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 624 newly awarded restricted stock units, 6,409 previously reported restricted stock units, and 439 shares of common stock.

SEC source: 0001628280-23-002260 · wf-form4_167546523995287.xml · derivative · entry 2

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,596

Underlying: Common Stock, par value $0.01 per share · 19,596 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002260 · wf-form4_167546523995287.xml · nonDerivative · entry 1

Rott Roland · CIK 0001952159 · CEO, Ultrasound

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,964

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 2,231 newly awarded restricted stock units, 20,488 previously reported restricted stock units, and 245 shares of common stock.

SEC source: 0001628280-23-002258 · wf-form4_167546520581404.xml · derivative · entry 3

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,005

Underlying: Common Stock, par value $0.01 per share · 58,005 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002258 · wf-form4_167546520581404.xml · nonDerivative · entry 1

Kass-Hout Taha · CIK 0001960652 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,606

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

SEC source: 0001628280-23-002256 · wf-form4_167546517834556.xml · derivative · entry 2

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,112

Underlying: Common Stock, par value $0.01 per share · 43,112 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002256 · wf-form4_167546517834556.xml · nonDerivative · entry 1

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,364

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 4,910 newly awarded restricted stock units, 60,422 previously reported restricted stock units, and 32 shares of common stock.

SEC source: 0001628280-23-002255 · wf-form4_167546515533806.xml · derivative · entry 2

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,244

Underlying: Common Stock, par value $0.01 per share · 17,244 shares

Expires 2033-02-01

F4 · price: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock, of which 50% will become exercisable on February 1, 2025 and 50% will become exercisable on February 1, 2026.

SEC source: 0001628280-23-002255 · wf-form4_167546515533806.xml · nonDerivative · entry 1

Westrick Thomas J. · CIK 0001952674 · CEO, Patient Care Solutions

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,509

F1 · shares: Award of restricted stock units with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock, of which 50% will vest on February 1, 2025 and 50% will vest on February 1, 2026.

F2 · shares: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · balance_after: The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes 1,964 newly awarded restricted stock units and 12,545 previously reported restricted stock units.

SEC source: 0001205247-23-000002 · wf-form4_167969165363124.xml · nonDerivative · entry 1

CULP H LAWRENCE JR · CIK 0001205247 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By family trusts

Disclosed balance after: 1,272

F1 · date: Filed late due to an administrative error.

SEC source: 0000899243-23-001112 · doc4.xml · derivative · entry 3

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,421

Underlying: Common stock, par value $0.01 per share · 36,421 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001112 · doc4.xml · derivative · entry 2

Jimenez Frank R · CIK 0001465175 · GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,853

Underlying: Common stock, par value $0.01 per share · 21,853 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001116 · doc4.xml · derivative · entry 2

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,395

Underlying: Common stock, par value $0.01 per share · 20,395 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F3 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F3 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F3 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001116 · doc4.xml · derivative · entry 1

Arduini Peter J · CIK 0001323134 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,023

Underlying: Common stock, par value $0.01 per share · 89,023 shares

Expires 2032-03-01

F1 · price: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will become exercisable on March 1, 2024 and 50% will become exercisable on March 1, 2025.

F1 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare Technologies Inc. ("GE HealthCare") common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will become exercisable on March 1, 2024 and 50% will become exercisable on March 1, 2025.

SEC source: 0000899243-23-001120 · doc4.xml · derivative · entry 2

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,779

Underlying: Common stock, par value $0.01 per share · 32,779 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F2 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F2 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001120 · doc4.xml · derivative · entry 1

Larson Betty D · CIK 0001617903 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,389

Underlying: Common stock, par value $0.01 per share · 16,389 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

F2 · price: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F2 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F2 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by General Electric Company ("GE") as a result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare by GE to holders of GE common stock on a pro rata basis (the "Spin-Off"), of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 17

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,569

Underlying: Common stock, par value $0.01 per share · 14,569 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F10 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

F10 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2024 and 50% will vest on March 1, 2025.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 16

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,209

Underlying: Common stock, par value $0.01 per share · 8,209 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F9 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024.

F9 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on July 1, 2023 and 50% will vest on July 1, 2024.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 15

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,846

Underlying: Common stock, par value $0.01 per share · 14,846 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F8 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

F8 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on March 1, 2023 and 50% will vest on March 1, 2024.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 14

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,555

Underlying: Common stock, par value $0.01 per share · 19,555 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F7 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

F7 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will vest on August 3, 2023 and 50% will vest on August 3, 2024.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 13

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,243

Underlying: Common stock, par value $0.01 per share · 3,243 shares

Expires not disclosed

F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare common stock.

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F6 · derivative.exercise_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

F6 · derivative.expiration_date: Award of restricted stock units with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% will vest on March 2, 2023.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 12

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,191

Underlying: Common stock, par value $0.01 per share · 66,191 shares

Expires 2031-07-01

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F4 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% will become exercisable on July 1, 2023 and 50% will become exercisable on July 1, 2024.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 11

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,615

Underlying: Common stock, par value $0.01 per share · 28,615 shares

Expires 2030-03-02

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 10

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 240

Underlying: Common stock, par value $0.01 per share · 240 shares

Expires 2030-03-02

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F3 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 50% is exercisable immediately and 50% will become exercisable on March 2, 2023.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 9

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,037

Underlying: Common stock, par value $0.01 per share · 4,037 shares

Expires 2029-04-11

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 8

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,967

Underlying: Common stock, par value $0.01 per share · 5,967 shares

Expires 2029-03-19

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.

SEC source: 0000899243-23-001113 · doc4.xml · derivative · entry 7

Makela Jan · CIK 0001951803 · CEO, Imaging

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,701

Underlying: Common stock, par value $0.01 per share · 54,701 shares

Expires 2028-12-21

F1 · price: The transactions reported herein are the result of the consummation on January 3, 2023 of the distribution of approximately 80.1% of the shares of common stock of GE HealthCare Technologies Inc. ("GE HealthCare") by General Electric Company ("GE") to holders of GE common stock on a pro rata basis (the "Spin-Off"). These transactions are voluntarily reported notwithstanding the exemption provided by Rule 16a-9.

F2 · derivative.exercise_date: Award of an employee stock option with respect to GE HealthCare common stock resulting from the conversion of certain equity incentive awards previously granted by GE as a result of the Spin-Off, of which 100% is fully exercisable immediately.